Cancer Survival in Australia 2001

Full publication (2.53M PDF)

• Preliminary material (123K PDF)
  • Title page and verso
  • Contents
  • List of tables
  • List of figures
  • Preface
  • Contributors
  • Executive summary
• Sections
  1. Introduction (52K PDF)
     • Content of this report
     • Measurement
       • Cancer incidence
       • Cancer Mortality
       • Survival
     • Previous studies
     • International Studies
  2. Method Overview (33K PDF)
     • Relative survival analysis
     • Survival period
     • Interpretation of survival measures
  3. All cancers (703K PDF)
     • Introduction
     • Incidence and mortality
     • Survival by period of diagnosis
     • Survival by age at diagnosis
     • International comparisons
     • Survival by individual cancer site
     • Comparison of survival by period of diagnosis for individual cancer sites
  4. Cancer of the stomach (447K PDF)
  5. Cancer of the colon (446K PDF)
  6. Cancer of the rectum (446K PDF)
  7. Cancer of the pancreas (443K PDF)
  8. Cancer of the lung (529K PDF)
     • Small-cell carcinoma of the lung
     • Non-small-cell carcinoma of the lung
     • Adenocarcinoma of the lung
  9. Cancer of the skin-melanoma (447K PDF)
  10. Cancer of the breast (female) (411K PDF)
  11. Cancer of the uterus (411K PDF)
  12. Cancer of the cervix (446K PDF)
      • Squamous cell carcinoma
      • Adenocarcinoma
  13. Cancer of the ovary (443K PDF)
  14. Cancer of the prostate (411K PDF)
  15. Cancer of the testi (410K PDF)
  16. Cancer of the bladder (447K PDF)
  17. Cancer of the kidney (523K PDF)
      • Transitional cell carcinoma of the kidney
      • Renal cell carcinoma of the kidney
  18. Cancer of the brain (558K PDF)
  19. Cancer of the thyroid (444K PDF)
  20. Cancer of unknown primary site (389K PDF)
      • Adenocarcinoma of unknown primary site
  21. Hodgkin's disease (441K PDF)
  22. Non-Hodgkin's lymphoma (568K PDF)
  23. Leukaemia (532K PDF)
      • Acute lymphatic leukemia
      • Acute myeloid leukemia
      • Chronic lymphatic leukemia
      • Chronic myeloid leukemia
• End matter
  • Appendixes
    1. Methods (382K PDF)
       • Objective
       • Relative survival analysis
       • Confidentiality
       • Data sources
         • National Cancer Statistics Clearing House (NCSCH)
         • National death Index (NDI)
         • Life tables
       • Confidence intervals
       • Data processes
         • NCSCH and NDI matching
         • Cancer registries' practices in resolving matches between the NCSCH and the NDI
         • NCSCH internal matching
         • Final analysis data set
    2. Topography codes
  • References (363K PDF)

[ top ]